New Search

If you are not happy with the results below please do another search

1030 search results for:


HORIBA UK expands clinical chemistry portfolio with new POINTE G6PD assay kit

HORIBA UK has expanded its clinical chemistry portfolio with the addition of a new test kit for Glucose-6-phosphate dehydrogenase (G6PD) from Pointe Scientific. HORIBA is distributing this cell function assay to the UK market following its acquisition of US-based Pointe Scientific in 2021. Used for the quantitative determination of G6PD enzyme activity in blood, the […]


EC approves Polpharma Biologics’ Tyruko biosimilar for MS

Polpharma Biologics, an international biotech company focused on developing and manu­facturing biosimilars, has received approval from the European Commission for Tyruko (natalizumab) as the first and only biosimilar for relapsing forms of multiple sclerosis (MS) in Europe. Tyruko was developed by Polpharma Biologics and will be commercialized by its collaboration partner Sandoz.